Nasacort approved in 2- to 5-year-olds

A new allergy drug for children will soon be on the market: The FDA has approved Sanofi-Aventis' Nasacort for children between the ages of 2 and 5 years old for the treatment of allergies. The FDA previously approved the medication for the treatment of individuals who were at least 6 years old. Sanofi release

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

After a jury ordered Gilead's Kite Pharma to pay $752 million for CAR-T patent infringement, BMS is asking for punitive damages in that amount, too.